Harold E. Lebovitz, MD

Harold E. Lebovitz, MD
Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes, State University of New York (SUNY) Health Sciences Center, Brooklyn

Address: Harold E. Lebovitz, MD, 416 Henderson Avenue, Staten Island, NY 10310

Dr. Lebovitz has indicated that he has received grant or research support from the Bristol-Myers Squibb, GlaxoSmithKline, and Novo Nordisk corporations; serves as a consultant for the Amylin, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceutica, Merck-Lipha, Novartis, Novo Nordisk, Pfizer, and Takeda corporations; is on the speakers’ bureaus of all of the above plus the Aventis corporation; and is a major stock shareholder in the Bayer, Bristol-Myers Squibb, and GlaxoSmithKline corporations.

Harold E. Lebovitz, MD
Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes, State University of New York (SUNY) Health Sciences Center, Brooklyn

Address: Harold E. Lebovitz, MD, 416 Henderson Avenue, Staten Island, NY 10310

Dr. Lebovitz has indicated that he has received grant or research support from the Bristol-Myers Squibb, GlaxoSmithKline, and Novo Nordisk corporations; serves as a consultant for the Amylin, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceutica, Merck-Lipha, Novartis, Novo Nordisk, Pfizer, and Takeda corporations; is on the speakers’ bureaus of all of the above plus the Aventis corporation; and is a major stock shareholder in the Bayer, Bristol-Myers Squibb, and GlaxoSmithKline corporations.

Harold E. Lebovitz, MD
Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes, State University of New York (SUNY) Health Sciences Center, Brooklyn

Address: Harold E. Lebovitz, MD, 416 Henderson Avenue, Staten Island, NY 10310

Dr. Lebovitz has indicated that he has received grant or research support from the Bristol-Myers Squibb, GlaxoSmithKline, and Novo Nordisk corporations; serves as a consultant for the Amylin, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceutica, Merck-Lipha, Novartis, Novo Nordisk, Pfizer, and Takeda corporations; is on the speakers’ bureaus of all of the above plus the Aventis corporation; and is a major stock shareholder in the Bayer, Bristol-Myers Squibb, and GlaxoSmithKline corporations.